MCL 0020
CAS: 475498-26-1
Ref. 3D-AUA49826
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
MCL 0020 is a small molecule drug that has been shown to alleviate the cognitive deficits in a transgenic mouse model of Alzheimer's disease. MCL 0020 binds to the element binding protein and increases the levels of melanocortin, which enhances long-term potentiation and synaptic plasticity. MCL 0020 also modulates synaptic dysfunction and reverses synaptic loss in a transgenic mouse model of Alzheimer's disease. The potential for MCL 0020 as an Alzheimer's treatment is highlighted by its ability to significantly improve cognitive function in mice with an app/ps1 transgenic, which mimics early-stage Alzheimer's pathology.
Propiedades químicas
Consulta técnica sobre: 3D-AUA49826 MCL 0020
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
